Join us for afternoon tea at the House of Lords
Sarah Joiner, Vice-Chair of Trustees at the MS Trust, invites you to an afternoon tea at the House of Lords hosted by Baroness Gardner of Parkes. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - May 4, 2015 Category: Neurology Source Type: news
Pregnancy decisions with MS
Jo Dunk talks about the choices she and her husband made when considering having another baby after her diagnosis with MS.
Kent Online
Pregnancy - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - May 4, 2015 Category: Neurology Source Type: news
Measuring nerve degeneration
Research has found that whilst atrophy isn't seen in the spinal cords of people with early primary progressive MS, there is evidence that nerve messages aren't being transmitted properly and that there are changes in the integrity of nerves.
MS Research Australia
Primary progressive MS - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - May 4, 2015 Category: Neurology Source Type: news
Anti-LINGO-1, biotin and phenytoin results reported at AAN 2015
(Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - May 4, 2015 Category: Neurology Source Type: news
AAN round up
A reviews of presentations from last month's American Academy of Neurology meeting. Includes daclizumab, 11 year data on interferon beta-1b, the negative fingolimod in primary progressive MS trial, anti-LINGO-1, biotin - plus stem cells, salt, obesity and marriage.
National MS Society (USA)
Latest MS research updates (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - May 3, 2015 Category: Neurology Source Type: news
Mindfulness and progressive MS
A small study in London has shown mindfulness is helpful in reducing pain, distress and depression in people with progressive MS.
Daily Mail
Meditation and mindfulness - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - May 1, 2015 Category: Neurology Source Type: news
Last chance to join Rick on London cycle challenge
Well done to Rick Halsall, who took part in a 10 hour static cycle ride in Tesco Southport last Saturday as part of his training and fundraising for a 100 mile cycle from London to Surrey. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - April 29, 2015 Category: Neurology Source Type: news
Neuroprotection in MS
Short video interview with a researcher at the AAN conference talking about the potential of neuroprotective treatments.
HCP Live
Neuroprotection - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - April 28, 2015 Category: Neurology Source Type: news
MS Awareness Week
A round up of various MS related issues and myths including who gets MS, what people with MS don't want to be called and some of the unexpected benefits that might come with a diagnosis of MS.
Huffington Post
MS Awareness Week (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - April 26, 2015 Category: Neurology Source Type: news
MS Awareness Week 2015
begins today. This year at the MS Trust we're focusing on the importance of MS specialist services to people affected by MS with our Heart of MS Care campaign. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - April 26, 2015 Category: Neurology Source Type: news
London Marathon 2016 ballot opens on Monday 4 May
If you would like to run the Virgin Money London Marathon on 24 April 2016 to support people affected by multiple sclerosis, don't forget to enter the public ballot for a place when it opens on Monday 4 May. You can also contact the MS Trust if you'd like to apply for a Gold Bond charity place. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - April 25, 2015 Category: Neurology Source Type: news
MD1003 (Biotin) encouraging for progressive MS
A phase III trial shows evidence that MD1003 (Biotin) may be a safe and effective way of treating progressive MS. After a year on treatment, 1 in 6 of the treatment group showed a decrease of at least 0.5 on the EDSS measure of disability compared to none in the placebo group. The application process to license the drug is expected to begin by the end of the year. Presented at the American Academy of Neurology (AAN) meeting.
Neurology Advisor
MedPage Today
Progressive forms of MS - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - April 23, 2015 Category: Neurology Source Type: news
Gilenya fails in progressive MS / Tysabri injections
A round up of presentations from AAN includes a study that found fingolimod (Gilenya) didn't slow progressive MS and research that shows injections of natalizumab (Tysabri) were as effective as infusions. Presented at the American Academy of Neurology (AAN) meeting.
MedPage Today
Fingolimod (Gilenya) - A to Z of MS
Natalizumab (Tysabri) - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - April 23, 2015 Category: Neurology Source Type: news
Study shows MS drugs are cost effective
The six year data from the ten year Risk-sharing Scheme project has found that the beta interferon drugs and glatiramer acetate are cost effective treatments for the NHS. People taking one of these drugs showed a slower increase in EDSS measures than predicted for untreated controls.
Pharmaceutical Journal
Risk-sharing Scheme (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - April 23, 2015 Category: Neurology Source Type: news
Good luck to our 2015 London Marathon team!
There will be 53 runners taking part in the London Marathon this Sunday in aid of the MS Trust, including Kenny Smith (pictured) who is running his 10th London Marathon. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - April 23, 2015 Category: Neurology Source Type: news
